Skip to Content

mNEXSPIKE dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

Licence status
Authorised: 12/02/2026
Active substances
mRNA-1283
Dosage Form
Dispersion for injection in pre-filled syringe
Licence number
EU/1/25/2010/001-006
Licence holder
Moderna Biotech Spain S.L.

Licence information

ATC code
J07BN01 covid-19, RNA-based vaccine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
12/02/2026